Lincoln National Corp increased its holdings in shares of Kimberly-Clark Co. (NYSE:KMB – Get Rating) by 2.8% in the third quarter, according to its most recent disclosure with the SEC. The firm owned 8,956 shares of the company’s stock after purchasing an additional 247 shares during the period. Lincoln National Corp’s holdings in Kimberly-Clark were worth $1,007,000 as of its most recent filing with the SEC.
A number of other hedge funds and other institutional investors have also bought and sold shares of KMB. New Millennium Group LLC bought a new position in Kimberly-Clark during the second quarter worth about $27,000. Wagner Wealth Management LLC bought a new stake in shares of Kimberly-Clark during the second quarter worth approximately $28,000. Newbridge Financial Services Group Inc. boosted its holdings in shares of Kimberly-Clark by 103.4% during the third quarter. Newbridge Financial Services Group Inc. now owns 364 shares of the company’s stock worth $41,000 after acquiring an additional 185 shares during the period. Heritage Financial Services LLC bought a new stake in shares of Kimberly-Clark during the second quarter worth approximately $42,000. Finally, Apeiron RIA LLC bought a new stake in shares of Kimberly-Clark during the second quarter worth approximately $42,000. Institutional investors own 74.16% of the company’s stock.
Wall Street Analysts Forecast Growth
A number of brokerages have recently issued reports on KMB. UBS Group boosted their price objective on Kimberly-Clark from $129.00 to $136.00 and gave the stock a “neutral” rating in a report on Monday. Wells Fargo & Company boosted their price objective on Kimberly-Clark from $120.00 to $135.00 and gave the stock an “equal weight” rating in a report on Tuesday, January 3rd. Atlantic Securities upgraded Kimberly-Clark from a “neutral” rating to an “overweight” rating and set a $135.00 price objective for the company in a report on Wednesday, October 12th. Barclays boosted their price objective on Kimberly-Clark to $127.00 in a report on Thursday, October 27th. Finally, StockNews.com cut Kimberly-Clark from a “buy” rating to a “hold” rating in a research note on Monday. Four equities research analysts have rated the stock with a sell rating, nine have given a hold rating and one has issued a buy rating to the company. According to MarketBeat.com, Kimberly-Clark currently has an average rating of “Hold” and an average price target of $128.67.
Kimberly-Clark Stock Up 0.3 %
Kimberly-Clark (NYSE:KMB – Get Rating) last announced its quarterly earnings data on Tuesday, October 25th. The company reported $1.40 EPS for the quarter, missing the consensus estimate of $1.48 by ($0.08). Kimberly-Clark had a net margin of 8.84% and a return on equity of 250.21%. The firm had revenue of $5.05 billion for the quarter, compared to analyst estimates of $5.01 billion. During the same quarter in the prior year, the firm earned $1.62 earnings per share. The firm’s revenue for the quarter was up .9% on a year-over-year basis. Research analysts forecast that Kimberly-Clark Co. will post 5.6 EPS for the current fiscal year.
Kimberly-Clark Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Wednesday, January 4th. Shareholders of record on Friday, December 9th were given a dividend of $1.16 per share. The ex-dividend date of this dividend was Thursday, December 8th. This represents a $4.64 annualized dividend and a yield of 3.45%. Kimberly-Clark’s dividend payout ratio is currently 87.88%.
Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products worldwide. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The Personal Care segment offers disposable diapers, swimpants, training and youth pants, baby wipes, feminine and incontinence care products, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Depend, Plenitud, Softex, Poise, and other brand names.
- Get a free copy of the StockNews.com research report on Kimberly-Clark (KMB)
- Pliant Therapeutics Gaps 34% Higher: More Upside To Come?
- How Will Early 2023 Layoffs Affect These 5 Biotech Stocks?
- Is the Pain Over for Baudax Bio Investors after a 70% Spike?
- Will Rocket Lab’s First U.S. Launch Send Stock Into Stratosphere?
- 3 Retail Stocks Ringing the Register in 2023
Receive News & Ratings for Kimberly-Clark Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kimberly-Clark and related companies with MarketBeat.com's FREE daily email newsletter.